Cancer Consortium Prostate Pathology Committee the Bar Harbor Meeting of the Mouse Models of Human Definitions and Classification . The Consensus Report from Prostate Pathology of Genetically Engineered Mice :
暂无分享,去创建一个
M. Rubin | R. Cardiff | P. Humphrey | J. Sundberg | R. Roberts | J. Ward | M. Ittmann | R. Barrios | G. Thomas | N. Rozengurt | S. Shappell | Ron Herbert | R. Herbert
[1] D. Grignon,et al. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland , 2005, Virchows Archiv A.
[2] D. Bostwick,et al. High-grade prostatic intraepithelial neoplasia , 2004, Modern Pathology.
[3] R. Matusik,et al. Transgenic Mouse Models of Prostate Carcinoma: Anatomic, Histopathologic, and Molecular Considerations , 2003 .
[4] James R Lambert,et al. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. , 2003, Cancer research.
[5] J. Hicks,et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. , 2003, The American journal of pathology.
[6] T. Graeber,et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. , 2003, Cancer cell.
[7] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[8] R. Cardiff,et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. , 2003, Cancer research.
[9] Tsuey-Ming Chen,et al. Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model , 2003, The Prostate.
[10] M. Capecchi,et al. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate , 2003, Development.
[11] W. Isaacs,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .
[12] A. D'Amico,et al. Neoplasms of the Prostate , 2003 .
[13] M. Orringer,et al. Vanderbilt-Ingram Cancer Center , 2014 .
[14] R. Roberts,et al. Transgenic mouse models for prostate cancer. Identification of an androgen-dependent promoter and creation and characterization of the long probasin promoter-Large T antigen (LPB-Tag) model. , 2003, Methods in molecular medicine.
[15] R. Cardiff,et al. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. , 2002, Cancer research.
[16] Sam S. Chang,et al. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. , 2002, The Journal of urology.
[17] Jose J. Galvez,et al. Prostatic intraepithelial neoplasia in genetically engineered mice. , 2002, The American journal of pathology.
[18] P. Walsh. Predicting Cancer Following a Diagnosis of High-Grade Prostatic Intraepithelial Neoplasia on Needle Biopsy: Data on Men With More Than One Follow-Up Biopsy , 2002 .
[19] R. Cardiff,et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. , 2002, Cancer research.
[20] Peter A. Humphrey,et al. Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia , 2002, Molecular and Cellular Biology.
[21] R. Cardiff,et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] V. Castronovo,et al. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation * , 2002, The Prostate.
[23] J. Haseman,et al. Spontaneous Lesions in Control B6C3F1 Mice and Recommended Sectioning of Male Accessory Sex Organs , 2002, Toxicologic pathology.
[24] R. Cardiff,et al. Nkx 3 . 1 Mutant Mice Recapitulate Early Stages of Prostate Carcinogenesis 1 , 2002 .
[25] W. Steers. 5α-reductase activity in the prostate , 2001 .
[26] D. Bostwick,et al. Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia. , 2001, Urology.
[27] M. Kattan,et al. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. , 2001, Human pathology.
[28] J. Haseman,et al. A Retrospective Analysis of Background Lesions and Tissue Accountability for Male Accessory Sex Organs in Fischer-344 Rats , 2001, Toxicologic pathology.
[29] R. Shah,et al. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? , 2001, The American journal of pathology.
[30] J. Epstein,et al. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. , 2001, Human pathology.
[31] P. Pandolfi,et al. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse , 2001, Nature Genetics.
[32] F. Collins,et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Matusik,et al. Transgenic Mouse Models of Prostate Cancer , 2001 .
[34] R Montironi,et al. p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.
[35] J. McNeal,et al. Distinction between intraductal carcinoma of the prostate (IDC‐P), high‐grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression , 2000, The Prostate.
[36] T. Stamey,et al. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.
[37] M. Kattan,et al. Lymphovascular invasion as a predictor of disease progression in prostate cancer. , 2000, The American journal of surgical pathology.
[38] J. Jorcano,et al. Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] K. Nakayama,et al. Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. , 2000, Journal of biochemistry.
[40] J. Epstein,et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.
[41] J. Srigley,et al. Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens. , 1999, The American journal of surgical pathology.
[42] J. Clemens,et al. Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. , 1999, The Journal of urology.
[43] Y. Shimosato,et al. Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.
[44] Christopher P. Crum,et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.
[45] R. Cardiff,et al. Roles for Nkx3.1 in prostate development and cancer. , 1999, Genes & development.
[46] P. Walsh,et al. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. , 1999, Urology.
[47] W. Travis,et al. Histological Classification of Lung and Pleural Tumours , 1999 .
[48] P. Humphrey,et al. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] T. Stamey,et al. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. , 1998, The Journal of urology.
[50] J. McNeal,et al. Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma. , 1998, Human pathology.
[51] P. Argani,et al. Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures: further evidence of the mesodermal origin of the prostatic central zone. , 1998, The Journal of urology.
[52] D. Chan,et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. , 1998, The Journal of urology.
[53] T. Miki,et al. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of microdissected specimens. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[54] P. Scardino,et al. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. , 1998, Human pathology.
[55] A. Yang,et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.
[56] J. Epstein,et al. Histology and cellular kinetics of prostatic atrophy. , 1998, The American journal of surgical pathology.
[57] M. Rubin,et al. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. , 1998, The American journal of surgical pathology.
[58] R. DePinho,et al. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth , 1998, Nature.
[59] P. Humphrey,et al. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[60] A. Thomson,et al. Enlargement of the ampullary gland and seminal vesicle, but not the prostate in int-2/Fgf-3 transgenic mice. , 1998, Differentiation; research in biological diversity.
[61] R. Matusik,et al. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[62] A. Roberts,et al. Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen. , 1998, Carcinogenesis.
[63] F. Smedts,et al. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: New perspectives , 1998, The Prostate. Supplement.
[64] D. Bostwick,et al. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. , 1997, The American journal of surgical pathology.
[65] F. Smedts,et al. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate. , 1997, The American journal of pathology.
[66] M. Kattan,et al. Androgen-independent prostate cancer progression in the TRAMP model. , 1997, Cancer research.
[67] Mahlon D. Johnson,et al. Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis , 1997, The Journal of cell biology.
[68] R. T. Curtis,et al. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. , 1997, Genomics.
[69] D. Bostwick,et al. A review of clinical and pathological prostatitis syndromes. , 1997, Urology.
[70] D. Duboule,et al. Male accessory sex organ morphogenesis is altered by loss of function of Hoxd‐13 , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.
[71] J. McNeal,et al. Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. , 1996, The American journal of surgical pathology.
[72] J. Ward,et al. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations. , 1996, Cancer research.
[73] J. Rosen,et al. Metastatic prostate cancer in a transgenic mouse. , 1996, Cancer research.
[74] D. Bostwick,et al. Molecular biology of prostatic intraepithelial neoplasia , 1996, The Prostate.
[75] D. Bostwick. Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia , 1996, Cancer.
[76] J. McNeal,et al. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. , 1996, The American journal of surgical pathology.
[77] A. Partin,et al. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. , 1996, The American journal of surgical pathology.
[78] C. Perez-stable,et al. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[79] J. Cheville,et al. Postatrophic Hyperplasia of the Prostate: A Histologic Mimic of Prostatic Adenocarcinoma , 1995, The American journal of surgical pathology.
[80] D. Grignon,et al. Interobserver Reproducibility in the Diagnosis of Prostatic Intraepithelial Neoplasia , 1995, The American journal of surgical pathology.
[81] R. Matusik,et al. Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[82] P. Chow,et al. Quantitative electrophoretic study of the modification of sperm plasma membrane by the ampullary gland in the golden hamster. , 1995, Archives of andrology.
[83] J. Green,et al. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[84] T. Stamey,et al. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. , 1994, The Journal of urology.
[85] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[86] R. Cohen,et al. The neuroendocrine cell population of the human prostate gland. , 1993, The Journal of urology.
[87] J. Epstein,et al. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. , 1993, Human pathology.
[88] P. Walsh,et al. Relationship Between Perineural Tumor Invasion on Needle Biopsy and Radical Prostatectomy Capsular Penetration in Clinical Stage B Adenocarcinoma of the Prostate , 1993, The American journal of surgical pathology.
[89] D. Bostwick,et al. Architectural patterns of high-grade prostatic intraepithelial neoplasia. , 1993, Human pathology.
[90] J. McNeal. Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer , 1993, Cancer.
[91] J. McNeal. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. , 1992, Human pathology.
[92] M. Brawer. Prostatic intraepithelial neoplasia: A premalignant lesion , 1992, Journal of cellular biochemistry. Supplement.
[93] P. Scardino,et al. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. , 1991, The Journal of urology.
[94] P. Lange,et al. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. , 1991, Urology.
[95] J. Epstein,et al. Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate Carcinoma , 1989, The American journal of surgical pathology.
[96] T. Stamey,et al. Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.
[97] S. J. Higgins,et al. The endocrinology and developmental biology of the prostate. , 1987, Endocrine reviews.
[98] C. Logothetis,et al. Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases , 1987, Cancer.
[99] T. Stamey,et al. Keratin immunoreactivity in the benign and neoplastic human prostate. , 1985, Cancer research.
[100] J. McNeal,et al. Normal and pathologic anatomy of prostate. , 1981, Urology.
[101] D PRICE,et al. COMPARATIVE ASPECTS OF DEVELOPMENT AND STRUCTURE IN THE PROSTATE. , 1963, National Cancer Institute monograph.